-
ALSO READ
Ajanta Pharma Q4 PAT down 17% at Rs 94 cr
Ajanta Pharma Q1 net up 12 pc at Rs 106 cr
Ajanta Pharma consolidated net profit rises 11.60% in the June 2018 quarter
Ajanta Pharma standalone net profit rises 96.56% in the June 2018 quarter
Ajanta Pharma consolidated net profit declines 17.13% in the March 2018 quarter
-
Under ESOP
Ajanta Pharma at the Compensation Committee of the Board has at its meeting held today decided to allot 7,500 fully paid up equity shares of Rs. 2/- each, upon exercise of options. In view of the above, the paid up capital of the Company stands increased to Rs. 17,60,46,000 consisting 8,80,23,000 equity shares of Rs. 2/- each.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
RECOMMENDED FOR YOU